Erik D. Roberson MD PhD
Neurodegenerative, Dementia & Geriatrics
Rebecca Gale-Heersink Endowed Chair; Director, Alzheimer's Disease Center; Director, Killion Center for Neurodegeneration and Experimental Therapeutics
Join to view full profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Fax+1 205-975-7365
Dr. Roberson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Neurology, 2000 - 2003
Baylor College of MedicineInternship, Transitional Year, 1999 - 2000- Baylor College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - Present
AL State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2013-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2013-2017
Clinical Trials
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
- Safety Study of TPI-287 to Treat CBS and PSP Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Variations in the effect of pulse pressure on cognition based on blood pressure.Mubarick Saeed, Charles F Murchison, David S Geldmacher, Katie M Wheeler, Erik D Roberson
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 2026-07-01 - Features predicting data exclusion in imaging studies of Alzheimer's disease.Shaney Flores, Jalen Scott, Ruijin Lu, Yi Su, Sarah J Keefe
Alzheimer's & Dementia. 2026-06-21 - Interconnected influences of diet, gut microbiome, and metabolome on cognition across three metabolomics platforms.Lora Khatib, Lucas Patel, Siamak MahmoudianDehkordi, Jennifer S Labus, Julius Agongo
Research Square. 2026-06-11
Journal Articles
- Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-Insufficient MiceErik Roberson, MD, ScienceDirect
Press Mentions
Advancing Health Through DiscoveryJuly 22nd, 2025- $10 Million Endowment to UAB Will Support Parkinson’s, Alzheimer’s, Huntington’s and ALS Research and EducationApril 14th, 2025
- Heersink Office of Research Emphasizes Collaboration and Innovation at 2025 Annual Research RetreatMarch 4th, 2025
Grant Support
- UAB Alzheimer's Disease Research CenterUNIVERSITY OF ALABAMA AT BIRMINGHAM2024–2029
- UAB Training Program in NeurodegenerationUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2027
- UAB Training Program in NeurodegenerationUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2027
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
